Development of a Radiochemical Cyclooxygenase-1 and -2 in Vitro Assay for Identification of Natural Products as Inhibitors of Prostaglandin Biosynthesis

Journal of Natural Products
1998.0

Abstract

A radiochemical enzyme assay for studying cyclooxygenase (COX)-catalyzed prostaglandin biosynthesis in vitro was optimized with respect to both COX-1 and COX-2 activity. The assay can be used to assess the relative selectivity of plant-derived inhibitors on COX-1 and COX-2 Assay conditions were optimized for both enzymes with respect to concentration of cofactors (l-epinephrine, reduced glutathione, and hematin), activation time (enzyme and cofactors), reaction time, and pH. Moreover, the kinetic parameters, Km and Kcat, of both enzymes were estimated. Five COX inhibitors were used to validate the assay, indomethacin, aspirin, naproxen, ibuprofen, and the arylsulfonamide NS-398, all with different COX selectivity and time dependency. Time-dependent inhibition was determined by comparing the inhibition, with and without preincubation of enzyme and inhibitor. Two flavonoids, (+)-catechin and quercitrin, were examined with respect to inhibition of COX-catalyzed prostaglandin biosynthesis. (+)-Catechin showed equal inhibitory effects on the two enzymes. Quercitrin was found to be inactive toward both COX-1- and COX-2-catalyzed prostaglandin biosynthesis. The optimization procedure resulted in a considerable reduction of the amount of enzyme required for adequate prostglandin biosynthesis and a reliable method suited to evaluate natural products on inhibition of COX-2-catalyzed prostaglandin biosynthesis, as well as on COX-1.

Knowledge Graph

Similar Paper

Development of a Radiochemical Cyclooxygenase-1 and -2 in Vitro Assay for Identification of Natural Products as Inhibitors of Prostaglandin Biosynthesis
Journal of Natural Products 1998.0
Screening of Ubiquitous Plant Constituents for COX-2 Inhibition with a Scintillation Proximity Based Assay
Journal of Natural Products 2002.0
New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling
European Journal of Medicinal Chemistry 2018.0
2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0
Ursolic Acid from<i>Plantago</i><i>major</i>, a Selective Inhibitor of Cyclooxygenase-2 Catalyzed Prostaglandin Biosynthesis
Journal of Natural Products 1998.0
Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-tert-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series
Journal of Medicinal Chemistry 1999.0
COX-2 Inhibitory Effects of Naturally Occurring and Modified Fatty Acids
Journal of Natural Products 2001.0
Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors
Bioorganic &amp; Medicinal Chemistry 2010.0
Design and synthesis of [ 125 I]Pyricoxib: A novel 125 I-labeled cyclooxygenase-2 (COX-2) inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2016.0
Synthesis and biological evaluation of ester derivatives of indomethacin as selective COX-2 inhibitors
Medicinal Chemistry Research 2012.0